| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| 201116-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二叔丁基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C49H63O4P | |
| 201116-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二叔丁基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C49H63O4P | |
| 201115-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C53H43O4P | |
| 201115-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C53H43O4P | |
| 201115-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C53H43O4P | |
| 201114-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C53H43O4P | |
| 201114-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C53H43O4P | |
| 201114-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C53H43O4P | |
| 201113-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C39H43O4P | |
| 201113-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C39H43O4P | |
| 201113-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C39H43O4P | |
| 201112-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C39H43O4P | |
| 201112-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C39H43O4P | |
| 201112-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C39H43O4P | |
| 201111-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C51H67O6P | |
| 201111-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C51H67O6P | |
| 201111-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C51H67O6P | |
| 201110-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C51H67O6P | |
| 201110-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C51H67O6P | |
| 201110-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C51H67O6P | |
小泰
|
010-60710855
|